Impact of Adalimumab Withdrawal or Continuation on Severity of COVID-19 and Risk of IMID Relapse
Conditions:   Inflammatory Bowel Diseases;   Rheumatic Disorder Intervention:   Drug: Adalimumab Sponsor:   IRCCS San Raffaele Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2023 Category: Research Source Type: clinical trials

Safety and Efficacy of Adalimumab Therapy for Treatment of Behcet's Disease-related Uveitis in Sohag University Hospital
Condition:   Uveitis Intervention:   Drug: Humira Sponsor:   Sohag University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 13, 2023 Category: Research Source Type: clinical trials